About Phosphoacetylglucosamine mutase
Phosphoacetylglucosamine mutase (PGM3) is a protein
from Homo sapiens identified by UniProt accession
O95394, 542 residues long.
MolForge cross-references it against 0 known binders and
272 disease associations.
Target properties
| Protein name | Phosphoacetylglucosamine mutase |
| UniProt accession | O95394 |
| Gene | PGM3 |
| Organism | Homo sapiens |
| Length | 542 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (272)
Diseases linked to this target (Open Targets).
- immunodeficiency 23 · score 0.84
- severe combined immunodeficiency · score 0.46
- Combined immunodeficiency · score 0.46
- combined immunodeficiency · score 0.46
- hyper-IgE syndrome · score 0.46
- genetic disorder · score 0.41
- Intellectual disability · score 0.37
- pancreatic adenocarcinoma · score 0.21
- brain measurement · score 0.09
- bipolar disorder · score 0.08
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O95394-F1 | alphafold | PREDICTED | 95.49 | — |
Amino-acid sequence (542 residues)
MDLGAITKYS ALHAKPNGLI LQYGTAGFRT KAEHLDHVMF RMGLLAVLRS KQTKSTIGVM VTASHNPEED NGVKLVDPLG EMLAPSWEEH ATCLANAEEQ DMQRVLIDIS EKEAVNLQQD AFVVIGRDTR PSSEKLSQSV IDGVTVLGGQ FHDYGLLTTP QLHYMVYCRN TGGRYGKATI EGYYQKLSKA FVELTKQASC SGDEYRSLKV DCANGIGALK LREMEHYFSQ GLSVQLFNDG SKGKLNHLCG ADFVKSHQKP PQGMEIKSNE RCCSFDGDAD RIVYYYHDAD GHFHLIDGDK IATLISSFLK ELLVEIGESL NIGVVQTAYA NGSSTRYLEE VMKVPVYCTK TGVKHLHHKA QEFDIGVYFE ANGHGTALFS TAVEMKIKQS AEQLEDKKRK AAKMLENIID LFNQAAGDAI SDMLVIEAIL ALKGLTVQQW DALYTDLPNR QLKVQVADRR VISTTDAERQ AVTPPGLQEA INDLVKKYKL SRAFVRPSGT EDVVRVYAEA DSQESADHLA HEVSLAVFQL AGGIGERPQP GF
Explore Phosphoacetylglucosamine mutase with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets